Abstract
Two patients with infantile phytanic acid storage disease (infantile Refsum disease), one of whom showed the presence of morphologically normal peroxisomes in a liver biopsy, were treated with a low phytanic acid diet for more than 2 years and the effects of treatment on certain clinical, biochemical and ultrastructural parameters were examined. Both patients showed evidence of either an improvement or stabilisation in their clinical condition. Plasma phytanic acid levels decreased to near normal values in approximately 6 weeks after the introduction of the diet; plasma pipecolic acid also declined markedly but the decrease was not so rapid and its level remained abnormal. C26∶C22 fatty acid ratios decreased very slowly and even after 2 years the values remained grossly abnormal. Despite the marked reduction of phytanic acid in the liver, there was an increase in the C26∶C22 fatty acid ratios and this appeared to be paralleled by an increase in inclusion bodies. Our data suggest that some patients with the infantile form of Refsum disease may show some clinical benefit from dietary management and this is reflected biochemically by decreases in the plasma levels of phytanic acid and pipecolic acid.
Similar content being viewed by others
Abbreviations
- VLCFA:
-
very long chain fatty acids
- ALD:
-
adrenoleukodystrophy
References
Barka T, Anderson PJ (1962) Histochemical methods for acid phosphatase using hexazonium pararosanilin as coupler. J Histochem Cytochem 10:741–753
Barth PG, Schutgens RB, Bakkeren JAJM, Dingemans KP, Heymans HSA, Douwes AC, Van der Klei-Van Moorsel JM (1980) A milder variant of Zellweger syndrome. Eur J Pediatr 144:338–342
Berkovic SF, Zajak JD, Warburton DJ, Merory JD, Fellenberg AJ, Poulos A, Pollard AC (1983) Adrenomyeloneuropathy: Clinical and biochemical diagnosis. Aust NZ J Med 13:594–600
Budden SS, Kennaway NG, Buist N, Poulos A, Weleber RG (1986) Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children. J Pediatr 108:33–39
Chang YF (1978) Lysine metabolism in the rat brain: the pipecolic acid forming pathway. J Neurochem Res 30:347–354
Chang YF (1982) Lysine metabolism in the human and the monkey. Demonstration of pipecolic acid formation in the brain and other organs. Neurochem Res 7:577–588
Eldjarn L, Stokke O (1979) Biochemical and dietary aspects of Refsum disease. In: Dyck PJ, Thomas PK, Lambert EH (eds) Peripheral neuropathy. Saunders, Philadelphia
Eldjarn L, Try K, Stokke E, Munthe-Kaas WA, Refsum S, Steinberg D, Avigan J, Mize C (1966) Dietary effects of serum phytanic acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis. Lancet I:691–693
Folch J, Lees M, Sloane-Stanley G (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509
Giacobini E (1976) Piperidine: a new neuromodulator or a hypogenic substance. Adv Biochem Psychopharmacol 15:17–56
Giacobini E, Nomura Y, Schmidt-Glenewinkel T (1980) Pipecolic acid: origin biosynthesis and metabolism in the brain. Cell Mol Biol 26:135–146
Gibberd FB, Page NGR, Billimoria JD, Retsas S (1979) Heredopathia atactica polyneuritiformis (Refsum disease) treated by diet and plasma-exchange. Lancet I:575–578
Goldfischer S, Moore CL, Johnson AB (1973) Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 182:62–64
Goldfischer S, Collins J, Rapin I, Colthoff-Schiller G, Chang CH, Nigro M, Black VH, Javitt N, Moser HW, Lazarow PB (1985) Peroxisomal defects in neonatal onset and X-linked adrenoleukodystrophies. Science 227:67–69
Kase Y, Okano Y, Yamanishi Y (1970) In vivo production of piperidine from pipecolic acid in the rat. Life Sci 9:1381–1387
Kase Y, Takahama K, Hashimoto T, Kaisaku J, Okano Y, Miyata T (1980) Electrophoretic study of pipecolic acid, a biogenic amino acid, in the mammalian brain. Brain Res 193:608–613
Masters-Thomas A, Barles J, Billimoria JD, Clemens ME, Gibberd AB, Page NR (1980) Heredopathia atactica polyneuritiformis (Refsum disease). Clinical features and dietary management. J Hum Nutr 34:245–250
Novikoff AB, Goldfischer S (1969) Visualisation of peroxisomes (microbodies) and mitochondria with diaminobenzidine. J Histochem Cytochem 17:675–680
Ogier H, Roels F, Cornelis A, Poll-The BT, Scotto JM, Odievre M, Saudubray JM (1985) Absence of hepatic peroxisomes in a case of infantile Refsum disease. Scand J Clin Lab Invest 45:767–768
Poll-The BT, Ogier H, Saudubray JM, Schutgens RBH, Wanders RJA, van den Bosch H, Schrakamp G (1986) Impaired plasmalogen metabolism in infantile Refsum disease. Eur J Pediatr 144:513–514
Poulos A (1981) Diagnosis of Refsum disease using [1-14C] phytanic acid as substrate. Clin Genet 20:247–253
Poulos A, Sharp P (1984) Plasma and skin fibroblast C26 fatty acids in infantile Refsum disease. Neurology 34:1606–1609
Poulos A, Whiting M (1985) Identification of 3α, 7α, 12α, trihydroxy-5β-cholestan 26-oic acid, an intermediate in cholic acid synthesis, in the plasma of patients with infantile Refsum disease. J Inherited Metab Dis 8:13–17
Poulos A, Sharp P, Whiting M (1984) Infantile Refsum disease: a variant of Zellweger syndrome? Clin Genet 26:579–586
Poulos A, Sharp P, Fellenberg AJ, Danks DM (1985) Cerebrohepato-renal (Zellweger) syndrome, adrenoleukodystrophy and Refsum disease: plasma changes and fibroblast phytanic acid oxidase. Hum Genet 70:172–177
Poulos A, Singh H, Paton B, Sharp P, Derwas N (1986) Accumulation and defective β-oxidation of very long chain fatty acids in Zellweger syndrome, adrenoleukodystrophy and Refsum disease variants. Clin Genet 29:397–408
Refsum S (1975) Heredopathia atactica polyneuritiformis: phytanic acid storage disease (Refsum disease). In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. 21:181–229
Refsum S (1980) Heredopathica atactica polyneuritiformis. Phytanic acid storage disease (Refsum disease) In: Sobne I (ed) Spinocerebellar degenerations. University of Tokyo Press, Tokyo, pp 313–338
Roels F, Cornelis A, Poll-The BT, Aubourg P, Ogier H, Scotto J, Saudubray JM (1986) Hepatic peroxisomes are deficient in infantile Refsum disease: a cytochemical study of 4 cases. Am J Med Genet 25:257–271
Schutgens RBH, Romeyn GJ, Wanders RJA, Van den Bosch H, Schrakamp G, Heymans HSA (1984) Deficiency of acyl-CoA: dihydroxyacetone phosphate acyl transferase in patients with Zellweger (cerebro-hepato-renal) syndrome. Biochem Biophys Res Commun 120:179–184
Schutgens RBH, Heymans HSA, Wanders RJA, van den Bosch H, Tager JDM (1986) Peroxisomal disorders: a newly recognised group of genetic diseases. Eur J Pediatr 144:430–440
Scotto JM, Hadchouel M, Odievre M, Laudat MH, Saudubray JM, Dulac O, Beucler I, Bean P (1982) Infantile phytanic acid storage disease, a possible variant of Refsum disease: three cases including ultrastructural studies of the liver. J Inherited Metab Dis 5:83–90
Steinberg D (1978) Phytanic acid storage disease. Refsum syndrome. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) Metabolic basis of inherited disease, 4th edn. McGraw-Hill, New York, pp 688–706
Steinberg D, Mize CE, Herndon JH, Fales HM, Engel WK, Vroom FQ (1970) Phytanic acid in patients with Refsum syndrome and response to dietary treatment. Arch Intern Med 125:75–87
Stokke O, Eldjarn L (1979) Toxicity of phytanic acid in Refsum disease. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 36. North Holland, Amsterdam, pp 347–349
Stokke O, Skrede S, Ek J, Bjorkhem I (1984) Refsum disease, adrenoleukodystrphy and the Zellweger syndrome. Scand J Clin Lab Invest 44:463–464
Tsuji S, Sano T, Ariga T, Miyatake T (1981) Increased synthesis of hexacosanoic acid (C26∶0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). J Biochem 90:1233–1236
Van Crugten JT, Paton B, Poulos A (1986) Partial deficiency of dihydroxyacetone phosphate acyltransferase in both classical and infantile Refsum diseases. J Inherited Metab Dis 9:163–168
Van Duyn MA, Moser AB, Brown FT, Sacktor N, Liv A, Moser HW (1984) The design of a diet restricted in saturated very long chain fatty acids: therapeutic application in adrenoleukodystrophy. Am J Clin Nutr 40:277–284
Wanders RJA, Saelman D, Heymans HSA, Schutgens RBH, Westerveld A, Poll-The BT, Saudubray JM, Van den Bosch H, Strijland A, Schram AW, Tager JM (1986) Genetic relation between the Zellweger syndrome, infantile Refsum disease and rhizomelic chondrodysplasia punctata. N Engl J Med 314:787–788
Wanders RJA, Schutgens RBH, Schrakamp G, van den Bosch H, Tager JM, Schram AW, Hashimoto T, Poll-The BT, Saudubray JM (1986) Infantile Refsum disease: deficiency of catalase-containing particles (peroxisomes) alkyldihydroxyacetone phosphate synthase and peroxisomal β-oxidation enzyme proteins. Eur J Pediatr 145:172–175
Wilson GN, Holmes RG, Custer J, Lykowitz JL, Stover J, Datta N, Hajra A (1986) Zellweger syndrome: diagnostic assays, syndrome delineation and potential therapy. Am J Med Genet 24:69–82
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robertson, E.F., Poulos, A., Sharp, P. et al. Treatment of infantile phytanic acid storage disease: clinical, biochemical and ultrastructural findings in two children treated for 2 years. Eur J Pediatr 147, 133–142 (1988). https://doi.org/10.1007/BF00442210
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442210